CPA Supports Measures To Curb Trade Imbalances Caused By Overvalued Dollar

CPA Supports Measures To Curb Trade Imbalances Caused By Overvalued Dollar

Realigning the dollar would be the most comprehensive and effective move to address the U.S. competitive disadvantage. It can be done either by a multilateral intervention agreement, or a MAC, which would be a federal tool to moderate foreign investment in dollar financial assets.

Vote Alert: CPA Urges Senators to Reject Amendments to Strike, Weaken FEOC Excise Tax

Vote Alert: CPA Urges Senators to Reject Amendments to Strike, Weaken FEOC Excise Tax

Any Senator who supports an amendment to remove or weaken the FEOC Excise Tax is directly endorsing China’s solar industry—dominated by companies using slave labor, powered by coal, and compromised by severe cybersecurity risks.

CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA Supports FEOC Excise Tax in President Trump’s “One Big Beautiful Bill” to Strengthen U.S. Solar Industry and National Security

CPA strongly endorses the FEOC Excise Tax in the Senate reconciliation bill as a critical step in protecting America’s solar manufacturing industry from reliance on subsidized and compromised Chinese components.

CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry

CPA Warns Senate Bill Contains Dangerous “Loophole” Benefiting China’s Solar Industry

CPA warned that the Senate version of President Trump’s reconciliation bill—known as the One Big Beautiful Bill—contains a critical loophole in both the Section 48E investment tax credit and 45Y production tax credit in the Inflation Reduction Act (IRA), creating an unintended but dangerous giveaway to China’s solar industry.

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

CPA Applauds Sen. Cotton for Introduction of the ‘PILLS Act’ – Legislation to Incentivize Domestic Production of Lifesaving Medicines

A smart policy like the ‘PILLS Act’ would prioritize domestic production of essential generics. It’s precisely the market signal needed to attract serious investment and rebuild the industry at home.